4 ms·
The pill just got approved so once manufacturing ramps up we should be good to go because they don’t target the spikes. The real issue is variants arising in o
by nojito 5y ago
The pill just got approved so once manufacturing ramps up we should be good to go because they don’t target the spikes.
The real issue is variants arising in other parts of the world where healthcare access is not great.